Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fortress Biotech Inc (NQ: FBIO )

1.630 +0.050 (+3.16%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 479,123
Open 1.580
Bid (Size) 1.620 (50)
Ask (Size) 1.650 (35)
Prev. Close 1.580
Today's Range 1.580 - 1.642
52wk Range 1.240 - 4.430
Shares Outstanding 22,587,038
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Fortress Biotech (FBIO) Stock Is Getting Hammered
Fortress Biotech shares are trading lower by 20% Friday afternoon. The company announced the pricing of a $8 million registered direct offering and concurrent private placements. 
Via Benzinga
FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q2 2024
FBIO stock results show that Fortress Biotech beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace

Performance

YTD
-39.41%
-39.41%
1 Month
-10.93%
-10.93%
3 Month
-18.50%
-18.50%
6 Month
-10.44%
-10.44%
1 Year
-43.79%
-43.79%

More News

Read More
Around $10M Bet On This Tech & Telecom Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Insiders Buying Fortress Biotech And 2 Other Stocks
Via Benzinga
Greenbrier, Fortress Biotech And 3 Stocks To Watch Heading Into Monday
Via Benzinga
Why Is Penny Stock Mustang Bio Trading Over 190% On Monday?
Via Benzinga
Why Fortress Biotech Shares Are Tumbling Today
Via Benzinga
Roth MKM Maintains Buy Rating for Fortress Biotech: Here's What You Need To Know
Via Benzinga
FBIO Stock Earnings: Fortress Biotech Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024
Via InvestorPlace
FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries
Via Get News
Exposures Product Safety
Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries
Via News Direct
Exposures Product Safety
Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries
Via TheNewswire.com
Exposures Product Safety
Alzamend Neuro And 3 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Fear & Greed Index Remains In 'Extreme Greed' Zone; S&P 500 Surges 24% In 2023
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Gold Moves Lower; Microbot Medical Shares Slide
Via Benzinga
Topics Stocks
Exposures US Equities
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Nasdaq Down Over 100 Points; Fortress Biotech Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.